glp-1 news oct 16 2025 Alarming rise in weight loss drug overdoses Two Years After Stopping GLP-1s,

In new results released Thursday on type 2 diabetes, with which patients tend to lose less weight with medications, Lilly said the drug lowered A1C blood sugar levels by an average of 1.7% to 2% at 40 weeks and produced average weight loss of up to 17%, or about 37 pounds

Apr 2024;30(4):610612

Without a preservative, the contamination risk after the first needle entry makes reuse inappropriate

Sci Rep 10: 17376, 2020

Comment: A number of comments were received in support of maintaining the APC assignments to New Technology APC 1511

In Phase 2 clinical trials, the safety profile was broadly consistent with other incretin-based therapies, with gastrointestinal side effects being the most commonly reported